ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

DYAI Dyadic International Inc

1.45
0.0599 (4.31%)
Last Updated: 05:57:49
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Dyadic International Inc DYAI NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0599 4.31% 1.45 05:57:49
Open Price Low Price High Price Close Price Previous Close
1.36 1.36 1.65 1.3901
more quote information »

Recent News

Date Time Source Heading
29/3/202407:00GLOBEDyadic Reports 2023 Full Year Results and Recent Company..
28/3/202423:30GLOBEDyadic Announces Change in Board and Management Leadership..
27/3/202423:30GLOBEDyadic to Attend Industry Events in April
26/3/202423:30GLOBEDyadic Announces Publication of C1 Monoclonal Antibody in..
21/3/202423:30GLOBEDyadic to Attend Future Food Tech Event March 21 – 22, 2024..
15/3/202407:30GLOBEDyadic to Report Full Year 2023 Financial Results and Host..
12/3/202400:57GLOBECORRECTION – Dyadic Announces Closing of Private Placement..
11/3/202423:45EDGAR2Form 8-K - Current report
11/3/202423:30GLOBEDyadic Announces Closing of Private Placement of $6.0..
02/3/202400:30GLOBEDyadic to Attend Industry Events in March
29/2/202400:30GLOBEDyadic Announces Strategic Partnership Agreement to..
22/2/202400:30GLOBEDyadic Advances Collaboration with Israel Institute for..
14/2/202408:41EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202400:30GLOBEDyadic and Cygnus Technologies Announce Partnership To..
07/2/202400:30GLOBEDyadic Announces Research and Development Collaboration..
02/2/202408:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202400:30GLOBEDyadic to Attend BIO CEO & Investor Conference and European..
05/1/202412:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202412:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202412:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202412:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202412:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202412:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202412:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202412:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202412:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202400:30GLOBEDyadic to Attend J.P. Morgan 42nd Annual Healthcare..
01/12/202300:30GLOBEDyadic Attends Investor Events in December
30/11/202300:30GLOBEDyadic Announces Top-Line Results from its Successful Phase..
21/11/202300:30GLOBEDyadic’s C1 Platform to be Used to Produce Vaccines..
09/11/202308:09EDGAR2Form 8-K - Current report
09/11/202308:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202308:00GLOBEDyadic Announces Third Quarter 2023 Financial Results and..
30/10/202323:30GLOBEDyadic to Present at Industry Events in November
26/10/202307:30GLOBEDyadic to Report Third Quarter 2023 Financial Results on..
09/10/202323:30GLOBEDyadic Appoints Doug Pace to Its Executive Leadership Team
07/10/202307:20EDGAR2Form 8-K - Current report
07/10/202307:10EDGAR2Form 8-K - Current report
05/10/202323:30GLOBEDyadic’s C1 Platform Selected by the Vaccine and..
29/9/202322:30GLOBEDyadic to Present at Industry and Investor Events in October
26/9/202322:30GLOBEDyadic and bYoRNA Announce a Collaboration Targeting the..
19/9/202322:30EDGAR2Form 8-K - Current report
19/9/202322:00GLOBEDyadic Announces Development and License Agreement to..
13/9/202306:30GLOBEDyadic to Present at BioProcess International
28/8/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
10/8/202306:10EDGAR2Form S-3 - Registration statement under Securities Act of..
10/8/202306:08EDGAR2Form 8-K - Current report
10/8/202306:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202306:00GLOBEDyadic Announces Second Quarter 2023 Financial Results..

Your Recent History

Delayed Upgrade Clock